logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

Bitcoin y las altcoins en una encrucijada: ¿nuevos máximos o corrección entrante?
WEEX causa sensación en BlockchainRIO 2025

También te puede interesar

Compartir
copy

Ganadores

Últimas noticias sobre criptomonedas

03:48

Coinbase to Include HBAR, MANTLE in COIN50 Index for Q4

03:18

In an Anthropic simulation test, AI Agents discovered a $4.6 million smart contract vulnerability.

23:52

Fed Future Meetings Risk Seeing Increased Disagreements Fueling Market Volatility

23:50

Tom Lee: BTC and ETH Risk-Reward Ratio Becoming Quite Attractive

23:48

Coinbase is now live with Rayls (RLS) spot trading

Leer más
Comunitario
icon
icon
icon
icon
icon
icon
icon

Atención al cliente@weikecs

Cooperación empresarial@weikecs

Trading cuantitativo y MM[email protected]

Programa VIP[email protected]